We’re waiting for a new Petitions Committee

Petitions had to stop because of the recent general election. Once a new Petitions Committee is set up by the House of Commons, petitions will start again.

Find out more on the Petitions Committee website

Closed petition Increase dedicated funding for childhood cancer research

The Government & Parliament must ensure more research funding in the UK is dedicated to childhood cancer research, which currently makes up only 2-3% of cancer research funding in the UK. We need investment into new treatments, to replace outdated & harmful drugs that have not changed in decades.

More details

I do not want other mums to have to suffer the most horrendous cancer journey like I have. No mother should have to witness their child enduring the most horrific pain caused by cancer, or to witness the debilitating after-effects of outdated and harmful treatments. My beautiful daughter, Sophie, at just 10 years of age, was taken from us on 18th September 2021 by this horrid disease. We must provide more funding to find new drugs and a cure for childhood cancers.

This petition is closed All petitions run for 6 months

16,026 signatures

Show on a map


Government responded

This response was given on 12 October 2021

Research is crucial to tackling childhood and other cancers. NIHR cancer research spending increased from £101 million in 2010/11 to £138 million in 2019/20, the largest investment in a disease area.

Read the response in full

Being diagnosed with cancer is devastating for anyone, especially for children and their families.

There has been a lot of progress in the treatment of childhood cancers over the last forty years, with the majority of children now surviving cancer. Sadly, this is not yet the case for certain childhood cancers such as brain cancer, neuroblastoma, and rhabdomyosarcoma.

More research is crucial. This is why DHSC spends £1bn per year in health research through the National Institute for Health Research (NIHR). NIHR cancer research spending has risen from £101 million in 2010/11 to £138 million in 2019/20, the largest investment in a disease area.

In May 2018 the Government announced £40 million over five years for brain tumour research as part of the Tessa Jowell Brain Cancer Mission. This includes funding for childhood cancers.

Funding is invested through the NIHR to support a wide range of research from early translational and experimental medicine research, through clinical, and onto applied health and care research. In essence this will support the translation of laboratory discoveries into treatments and better care for patients, including children.

We are working closely with partners via the Tessa Jowell Brain Cancer Mission. The Mission has made truly excellent progress since it was established in 2018. Through the Mission, we have held customised workshops to support the research community in submitting more fundable research applications to the NIHR. We will also be providing funding for the research training elements of the Tessa Jowell Fellowships to train specialist brain tumour oncologists, and thus helping to grow the research community.

The following are specific examples of research that the NIHR is funding into childhood cancers:

Tessa Jowell BRAIN MATRIX. This is an exciting new trials platform that will give people with brain cancer, including children, access to trials of treatments that are best suited to their individual tumours.

Biomede. The NIHR Clinical Research Network supported the recruitment of children with Diffuse Intrinsic Pontine Glioma (DIPG) to the Biological Medicine for DIPG Eradication, otherwise known as Biomede. Biomede is an international, multi-centred, and adaptive phase II trial of treatment for DIPG.

NIHR Great Ormond Street Biomedical Research Centre (BRC) is researching the use of imaging to assess the efficacy of induction chemotherapy for high-risk neuroblastoma.

Experimental Cancer Medicine Centres (ECMCs). The early-phase studies supported by ECMC Paediatric Network that the NIHR funds in partnership with Cancer Research UK and Scotland.

NIHR Newcastle Biomedical Research Centre is studying the genetic profiles of high-risk neuroblastomas to provide predictive and prognostic biomarkers for current and future targeted therapies

NIHR Royal Marsden Biomedical Research Centre.
Developing preclinical models of neuroblastoma and childhood soft tissue sarcoma cells for the development of target-driven drug treatment.
Early Phase Research into childhood cancers - the Centre is undertaking world-leading research for children with cancer. It developed a 91 gene panel that detects certain genomic mutations in childhood tumours.
Undertaking fundamental research on DIPG. This childhood brain tumour is comprised of multiple generations of different types of cancer cells, which makes it so difficult to treat.

Cancer trials and studies. The NIHR Clinical Research Network has over 800 cancer trials and studies recruiting or in set-up, including studies for children with cancer. Through the Network, the proportion of patients entering cancer clinical trials and studies is more than double that in any other country for which data exists, including the United States

Children and young people in research. The NIHR is committed to engaging children and young people to participate in research, supporting researchers and funders, as well as empowering children and young people to lead their own journey with research.

Headsmart is raising national awareness of the common signs and symptoms of brain tumours in children and teenagers. The NIHR is funding a Research Fellowship entitled ‘Childhood cancer diagnosis: quantifying national diagnostic intervals and developing professional and public decision support tools for earlier diagnosis’.

The NIHR welcomes funding applications for research into any aspect of human health, including childhood cancers. To encourage such proposals, we released a public announcement to the research community making clear our desire to receive brain tumour research funding applications. This has led to an increase in proposals, many of which have been funded. We continue to encourage further applications.

The Department continues to work closely with research funding partners, such as Cancer Research UK, the Medical Research Council and brain tumour charities, which fund research into new scientific discoveries.

Department of Health and Social Care

MPs hold inquiry into cancer services in England

The House of Commons Health and Social Care Committee is holding an inquiry into why cancer outcomes in England continue to lag behind comparable countries internationally. The Committee is examining evidence relating to the underlying causes of these differences.

The Committee is also considering what impact disruption to cancer services during the covid-19 pandemic have had on efforts to catch up, and whether the ambitions set out in the NHS Long Term Plan will help close the gap with the best performing countries worldwide.

Read about the inquiry here: https://committees.parliament.uk/work/1377/cancer-services/news/156443/mps-seek-evidence-on-why-england-lags-behind-in-cancer-survival/

You can find future announcements about the inquiry here: https://committees.parliament.uk/work/1377/cancer-services/

The submission period for written evidence for this inquiry has now passed, but you can view submitted written evidence here: https://committees.parliament.uk/work/1377/cancer-services/publications/

We’re letting you know about this inquiry because you signed a petition calling on the Government to increase dedicated funding for childhood cancer research, and we thought this inquiry may be of interest to you.

What is the Health and Social Care Committee?

The Health and Social Care Committee scrutinises the work of the Department of Health and Social Care and its associated public bodies. It examines government policy, spending and administration on behalf of the electorate and the House of Commons. It's a cross-party committee and is independent of the Government.

Find out more on their website: https://committees.parliament.uk/committee/81/health-and-social-care-committee/

You can get updates on their work by following the Committee on Twitter:

This is a ‘select committee’. Find out how Select Committees work:

You can also sign up to the UK Parliament newsletter for the latest information on how to get involved and make a difference: https://learning.parliament.uk/en/your-uk-parliament-newsletter-sign-up-form/

Share your views on improving cancer diagnosis and treatment with the Government

The Government is asking cancer patients, their relatives and NHS staff for their views on how it can save thousands more lives each year by improving the diagnosis and treatment of cancer in England.

Responses to the consultation will be used to inform the development of the Government’s 10-year Cancer Plan for England. The issues the Government is asking for views on include how to raise awareness of the signs and symptoms of cancer, and improving access to and experiences of cancer treatment.

Find out more and share your views: https://www.gov.uk/government/consultations/10-year-cancer-plan-call-for-evidence

The consultation closes on 1 April 2022. It is open to anyone aged 16 or over.

Who is running the consultation?

The consultation is being run by the Department for Health and Social Care (DHSC), the Government Department responsible for the NHS and oversight of social care in England.

Find out more about DHSC: https://www.gov.uk/government/organisations/department-of-health-and-social-care

What is the 10-Year Cancer Plan?

The 10-Year Cancer Plan for England will set out a new vision for how the NHS will deliver world-leading cancer care in England.

It will consider how to make the most of new innovations and what patient experience should look like in 2032. It will also consider how to build on lessons learned from the covid-19 pandemic. It is expected to be set out in the summer.

Find out more: https://www.gov.uk/government/news/health-and-social-care-secretary-to-launch-new-10-year-national-war-on-cancer

Childhood cancer outcomes to be debated by MPs

On Tuesday 26 April, MPs will hold a debate in the House of Commons chamber on childhood cancer outcomes. The debate will be led by Dame Caroline Dinenage MP.

The debate will begin after MPs have considered amendments made by the House of Lords to the Judicial Review and Courts Bill.

Watch the debate on Tuesday: https://parliamentlive.tv/Event/Index/9014962b-dc3b-449a-b2bc-4b9dae0ac634

You'll also be able to read a transcript of the debate a few hours after it has finished: https://hansard.parliament.uk/commons/2022-04-26

This will be a general debate, scheduled by the Backbench Business Committee. General debates allow MPs to debate important issues, however they do not end in a vote nor can they change the law.

Find out more about how Parliamentary debates work:

Find out more about the Backbench Business Committee:

Get involved in the work of the UK Parliament

Sign up to the Your UK Parliament newsletter for the latest information on how to get involved and make a difference: https://parliament.us16.list-manage.com/subscribe?u=3ad7e4c57a864f07e4db008c4&id=26d0645ea9

MPs investigate innovations in cancer care

A group of MPs called the Health and Social Care Committee are looking into innovations that can transform cancer diagnosis and treatment.

Read the Committee's press notice announcing this work.

The Committee is considering points including:

  • What innovations have the greatest potential to transform cancer diagnosis and treatment

  • How innovations in diagnosing and treating cancer can be deployed into frontline clinical settings

  • What can be learnt about innovative cancer diagnosis and treatment from international examples of best practice

  • How workforce planning is keeping up with innovations in the diagnosis and treatment of cancer

  • How the impact of innovations in cancer diagnosis and treatment on health inequalities is taken into account

What happens next?

The Committee is going to conduct oral evidence sessions where it will hear from experts in the sector as well as Government and NHS officials.

An evidence session is a hearing where MPs ask key experts, such as Ministers, academics and/or campaigners, questions on a particular topic. These experts are called "witnesses" and they help MPs to gain a deeper understanding of the topic.

The Committee will then consider all the evidence it has taken and publish a report of its findings with recommendations to the Government on any changes that might be needed.

For more information about the inquiry, visit the Committee's inquiry page.

What is the Health and Social Care Committee?

The Health and Social Care Committee is a cross-party group of MPs that conduct inquiries into issues in Health and Social Care in the UK.

The Health and Social Care Committee is a select committee.

Get involved in the work of the UK Parliament

Sign up to the Your UK Parliament newsletter for the latest information on how to get involved and make a difference.

MPs debate childhood cancer outcomes

On Tuesday 17 October, MPs took part in an adjournment debate in Parliament on childhood cancer outcomes. During the debate MPs discussed funding available for research into childhood cancers.

The debate was led by Emma Lewell-Buck MP. Will Quince MP, the Minister for Health and Secondary Care, responded for the Government.

What are Adjournment debates?

Adjournment debates are general debates which do not end in a vote. They give a backbench MP the opportunity to raise an issue and receive a response from a government minister.

Get involved in the work of the UK Parliament

Sign up to the Your UK Parliament newsletter for the latest information on how to get involved and make a difference.